Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
ICR commended for plans to work with commercial partners
The ICR has been commended for its approach to transforming its discoveries into new treatments for people with cancer by working with industry.
World-leading cancer researchers first in UK to receive NovaSeq - the latest genome sequencing technology
UK scientists now have access to a new kind of next-generation genome sequencer - NovaSeq - which could revolutionise their research to defeat cancer.
Scientists call for better use of chemical tools to improve cancer drug discovery
Chemical tools used in cancer research need to be selected more carefully, researchers have warned.
ICR awarded £30 million towards new Centre for Cancer Drug Discovery
The Institute of Cancer Research has secured a £30 million grant from the Higher Education Funding Council for England (HEFCE) towards the costs of building a new, state-of-the-art drug discovery facility.
ICR Awards Ceremony celebrates graduating students and pioneering researchers
Three internationally recognised cancer researchers have been honoured alongside graduating students and former staff members at the annual ICR Awards Ceremony.
First ever Teaching Week to promote the ICR’s academic excellence
The ICR will be underlining its credentials as a global leader in cancer research, education and training through a series of communication activities during its first ever Teaching Week.
Time since chemotherapy may predict response to olaparib in ovarian cancer
Women with advanced ovarian cancer who begin treatment with olaparib are more likely to respond to the drug if it has been more than a year since their last round of chemotherapy, according to new research.
Immunotherapy kinder than chemotherapy for patients with head and neck cancer
The immunotherapy nivolumab is kinder than chemotherapy for people with advanced head and neck cancer – easing many of the negative effects of the disease on patients’ quality of life.
ICR scientist Dr Sebastian Guettler awarded prestigious Lister Prize
Dr Sebastian Guettler, a Team Leader at The Institute of Cancer Research, London, has been recognised as one of the most promising young biomedical researchers in the UK and awarded a Lister Institute Research Prize Fellowship.
Seven new DNA regions linked to kidney cancer risk
Researchers have found seven new single-letter changes to DNA that are linked to an increased chance of developing renal cell carcinoma.
New three-in-one blood test opens door to precision medicine for prostate cancer
Scientists have developed a three-in-one blood test that could transform treatment of advanced prostate cancer through use of precision drugs designed to target mutations in the BRCA genes.
Better treatment for high-risk children’s cancer shown in major trial
Children with a high-risk, deadly form of neuroblastoma will benefit from a treatment regime that improves survival and reduces side-effects, following the publication of a major European trial.